The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProven Vct Regulatory News (PVN)

Share Price Information for Proven Vct (PVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.50
Bid: 58.00
Ask: 61.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.172%)
Open: 59.50
High: 59.50
Low: 59.50
Prev. Close: 59.50
PVN Live PriceLast checked at -
ProVen VCT is an Investment Trust

To achieve long-term returns from investing in a portfolio of quoted companies, qualifying investments in small and medium sized unquoted companies and non-qualifying investments permitted for liquidity management purposes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProVen VCT plc: Interim Management Statement

10 Feb 2023 15:21

ProVen VCT plc: Interim Management Statement

ProVen VCT plcInterim Management Statement for the nine months ended 30 November 2022

ProVen VCT plc (the “Company”) presents an Interim Management Statement for the nine-month period ended 30 November 2022. The statement also includes relevant financial information between the end of the period and the date of this announcement.

Performance

 Unaudited30 November2022Unaudited31 August2022Unaudited31 May2022Audited28 February2022
 PencePencePencePence
Net Asset Value per share (“NAV”)66.367.674.576.7
Dividends paid to date*79.0079.0075.2575.25
NAV plus dividends paid to date145.30146.60149.75151.95

*Dividends paid represent dividends paid since the consolidation of 5p Ordinary Shares into 10p Ordinary Shares in October 2012. Prior to this date, the Company paid dividends totalling 113.95p on the 5p Ordinary Shares.

Dividends paid or declaredOn 12 October 2022, the Company announced an interim dividend for the year ended 28 February 2023 of 1.75p per share. This dividend was paid on 2 December 2022 to shareholders on the register at 11 November 2022.

Investment portfolio summary at 30 November 2022

Portfolio summary

 Valuation
Venture capital investments£’000
  
Luxury Promise Limited9,794
MPB Group Limited6,932
Infinity Reliance Limited (t/a My 1st Years)6,173
Picasso Labs, Inc. (t/a CreativeX)5,392
Monica Vinader Limited5,359
Social Value Portal Ltd4,376
DeepCrawl Holding Company, Inc.4,156
Access Systems, Inc. (t/a Access Pay)4,000
WS HoldCo, PBC. (t/a WiredScore)3,877
Papier Ltd3,144
Other investments56,132
Total investments109,335
  
Cash at bank45,580
Other net current assets3,149
  
Net Assets158,064

Unquoted investments are valued at fair values established using the International Private Equity and Venture Capital Valuation Guidelines.

Investment activity during the three-month period ended 30 November 2022

Investment additions

 £’000
Gorillini NV (t/a Gorilla)2,437
Doctify Limited2,222
Plu&m Limited (t/a Plum Guide)88
 4,747

Investment disposals

 CostMarket value at 1 September 2022DisposalproceedsGainagainstcostRealisedgain in period
 £’000£’000£’000£’000£’000
Sealskinz Holdings Limited8348341,040206206
Lupa Foods Limited*10613713731-
 9409711,177237206

*Loan note disposal

Investment activity from 1 December 2022 to the date of this announcement

Investment additions

 £’000
Dash Brands Ltd2,718
Litta App Limited860
Arctic Shores Limited541
Commonplace Digital Limited380
 4,499

Investment disposals

 CostMarket value at 1 December 2022DisposalproceedsGain / (loss)againstcostRealisedGain / (loss) in period
 £’000£’000£’000£’000£’000
Firefly Learning Limited1,2021,2391,036(166)(203)
 1,2021,2391,036(166)(203)

Changes to share capitalOrdinarySharesof 10p each
As at 1 September 2022239,336,524
Shares bought back during the 3 months to 30 November 2022(819,282)
Shares issued during the 3 months to 30 November 2022-
As at 30 November 2022238,517,242

In the period from 1 December 2022 to the date of this announcement, 98,420 Ordinary Shares were repurchased and subsequently cancelled.

In addition, 1,110,056 Ordinary Shares were issued under the Company’s Dividend Reinvestment Scheme (“DRIS”) in relation to the dividend paid on 2 December 2022.

Material eventsIn February 2023, the Company agreed to the sale of portfolio company Aistemos Limited to RELX plc. The transaction is subject to customary regulatory approvals and is expected to be completed during the first quarter of 2023.

Other than the matters described above, there were no material events during the period from 1 September 2022 to 30 November 2022 or in the period from 1 December 2022 to the date of this announcement.

Further informationFurther information regarding the Company, can be found on Beringea's dedicated VCT website: www.provenvcts.co.uk or by contacting Beringea, the Investment Manager at provenvcts@beringea.co.uk or by telephone 020 7845 7820.

Beringea LLPCompany SecretaryTelephone 020 7845 7820-End

Date   Source Headline
26th Apr 20243:10 pmGNWProVen VCT plc: Issue of Equity
24th Apr 20241:43 pmGNWProVen VCT plc: Extension of 2024/2025 Offer
5th Apr 20243:57 pmGNWProVen VCT plc: Issue of Equity
2nd Apr 20244:15 pmGNWProVen VCT plc: Issue of Equity
28th Mar 20241:49 pmGNWProVen VCT plc: Total voting rights
13th Mar 20244:10 pmGNWProVen VCT plc: Issue of Equity
1st Mar 20241:26 pmGNWProVen VCT plc: Total voting rights
29th Feb 20244:49 pmGNWProVen VCT plc: Transaction in Own Shares
1st Feb 20244:00 pmGNWProVen VCT plc: Total voting rights
16th Jan 20243:17 pmGNWProVen VCT plc: Statement re. Offer for Subscription
2nd Jan 202412:04 pmGNWProVen VCT plc: Total voting rights
22nd Dec 20239:36 amGNWProVen VCT plc: Interim Management Statement
15th Dec 20234:54 pmGNWProVen VCT plc: Director/PDMR Shareholding
15th Dec 20234:50 pmGNWProVen VCT plc: Issue of Equity
4th Dec 20233:55 pmGNWProVen VCT plc: Total voting rights
21st Nov 20234:13 pmGNWProVen VCT plc: Transaction in Own Shares
7th Nov 20233:57 pmGNWProVen VCT plc: Half-yearly report
1st Nov 20235:46 pmGNWProVen VCT plc: Total voting rights
2nd Oct 20232:07 pmGNWProVen VCT plc: Total voting rights
19th Sep 202312:36 pmGNWIntention to Fundraise
6th Sep 20235:03 pmGNWProVen VCT plc: Director/PDMR Shareholding
1st Sep 202311:30 amGNWProVen VCT plc: Total voting rights
31st Aug 20234:50 pmGNWProVen VCT plc: Transaction in Own Shares
4th Aug 20232:49 pmGNWProVen VCT plc: Issue of Equity
4th Aug 202311:38 amGNWProVen VCT plc: Director/PDMR Shareholding
4th Aug 202311:36 amGNWProVen VCT plc: Issue of Equity
1st Aug 202312:04 pmGNWProVen VCT plc: Total voting rights
28th Jul 20233:36 pmGNWProVen VCT plc: Close of Offer to further applications
14th Jul 20232:03 pmGNWProVen VCT plc: Interim Management Statement
13th Jul 20234:35 pmGNWProVen VCT plc: Result of AGM
7th Jul 202310:32 amGNWProVen VCT plc: Issue of Equity
3rd Jul 202312:28 pmGNWProVen VCT plc: Publication of a supplementary prospectus
3rd Jul 202312:24 pmGNWProVen VCT plc: Total voting rights
27th Jun 202311:53 amGNWProVen VCT plc: Doc re. Annual Report and Accounts to 28 February 2023
21st Jun 20235:48 pmGNWProVen VCT plc: Transaction in Own Shares
12th Jun 20237:00 amGNWProVen VCT plc: Annual Financial Report
1st Jun 20236:04 pmGNWProVen VCT plc: Total voting rights
3rd May 20234:49 pmGNWProVen VCT plc: Total voting rights
27th Apr 20238:22 amGNWProVen VCT plc: Extension of 2023/2024 Offer
14th Apr 20234:40 pmGNWProVen VCT plc: Issue of Equity
5th Apr 202312:32 pmGNWProVen VCT plc: Issue of Equity
3rd Apr 20232:59 pmGNWProVen VCT plc: Total voting rights
30th Mar 20234:57 pmGNWProVen VCT plc: Issue of Equity
1st Mar 20234:39 pmGNWProVen VCT plc: Total voting rights
28th Feb 20235:57 pmGNWProVen VCT plc: Transaction in Own Shares
23rd Feb 20233:20 pmGNWProVen VCT plc: Director/PDMR Shareholding - Replacement Announcement
23rd Feb 20233:13 pmGNWProVen VCT plc: Issue of Equity - Replacement Announcement
20th Feb 20235:43 pmGNWProVen VCT plc: Director/PDMR Shareholding
20th Feb 20235:39 pmGNWProVen VCT plc: Issue of Equity
10th Feb 20233:21 pmGNWProVen VCT plc: Interim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.